Related Experiment Video
Updated: May 2, 2026

In Vitro Model of Physiological and Pathological Blood Flow with Application to Investigations of Vascular Cell Remodeling
Published on: November 3, 2015
Disturbed flow promotes endothelial senescence via a p53-dependent pathway
Christina M Warboys1, Amalia de Luca, Narges Amini
1From the British Heart Foundation Cardiovascular Science Unit, National Heart and Lung Institute (C.M.W., A.d.L., NA., R.K., W.-M.C., J.C.M., D.O.H.), Department of Aeronautics (S.J.S.), and MRC Clinical Sciences Centre (J.G.), Imperial College London, London, United Kingdom; Departments of Cardiovascular Science (L.L., H.D., S.H., S.B., P.C.E.) and Materials Science and Engineering (A.W., C.K.C.) and Insigneo Institute of In Silico Medicine (P.C.E.), University of Sheffield, Sheffield, United Kingdom; and Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom (M.R.B.).
Disturbed blood flow promotes endothelial cell senescence, a key factor in atherosclerosis, through a p53-p21 pathway. Sirtuin 1 activation can inhibit this process, potentially improving cardiovascular health.
Area of Science:
- Cardiovascular Biology
- Cellular Senescence
- Atherosclerosis Pathogenesis
Background:
- Atherosclerosis, while linked to systemic factors like high cholesterol, predominantly forms at arterial sites with disturbed blood flow patterns.
- The precise molecular mechanisms connecting disturbed flow-induced mechanical forces to arterial injury remain unclear.
- Endothelial cell (EC) senescence is investigated as a potential link between disturbed flow and arterial injury.
Purpose of the Study:
- To investigate the effects of disturbed and undisturbed blood flow on endothelial cell (EC) senescence.
- To elucidate the molecular pathways involved in flow-induced EC senescence.
- To explore potential therapeutic strategies targeting EC senescence in atherogenesis.
Main Methods:
- LDLR(-/-) mice on a high-fat diet were analyzed for EC senescence markers (β-galactosidase, p53) in aortic ECs.
- In vitro flow systems (orbital shaker, flow bioreactor) were used to expose cultured ECs to different flow conditions.
- Gene silencing (p53, p21) and pharmacological interventions (resveratrol, SRT1720) were employed to study signaling pathways and therapeutic potential.
Main Results:
- High-fat diet induced elevated senescence markers in aortic ECs at disturbed flow sites in mice.
- Disturbed flow in vitro promoted EC senescence via a p53-p21 signaling pathway, while undisturbed flow reduced it.
- Senescent ECs showed reduced migration, impairing arterial repair; Sirtuin 1 activation protected ECs from senescence.
Conclusions:
- Disturbed blood flow induces endothelial senescence through a p53-p21-dependent mechanism.
- Activation of Sirtuin 1 effectively inhibits disturbed flow-induced EC senescence.
- Targeting EC senescence via Sirtuin 1 activation presents a potential strategy for promoting cardiovascular health.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Peripheral Artery Disease I: Introduction

